Related by context. All words. (Click for frequent words.) 69 pharmacokinetic interactions 67 myopathy rhabdomyolysis 67 CYP #A# 66 probiotic supplementation 66 APTIVUS r 65 P glycoprotein inhibitors 65 ergot alkaloids 65 monoamine oxidase inhibitors 65 omeprazole Prilosec 65 pimozide 65 thiazide 65 uric acid lowering 64 primidone 64 CYP#A# inhibitors 64 antioxidant supplementation 64 pharmacodynamic parameters 64 selective modulator 64 lenalidomide dexamethasone 63 immunosuppressive agents 63 aspirin clopidogrel 63 bezafibrate 63 CYP#D# inhibitor 63 ursodeoxycholic acid 63 corticosteroid therapy 63 NUCYNTA R 63 Oral corticosteroids 63 HMG CoA reductase inhibitors 63 L lysine 63 cardioprotective effect 63 MAO inhibitors 63 antiplatelet drugs 63 H2 antagonists 63 INFERGEN 63 lipid lowering therapies 63 steroid dexamethasone 63 ritonavir boosted 63 anticoagulant warfarin 62 indinavir 62 antiplatelet medications 62 topical NSAIDs 62 clomipramine 62 anticholinergics 62 Celecoxib 62 anticholinergic effects 62 vasodilators 62 aldosterone antagonists 62 pyridostigmine 62 antiinflammatory 62 pentoxifylline 62 flecainide 62 Fibrates 62 IFN beta 62 INTEGRILIN R 62 mitochondrial toxicity 62 NAbs 62 Th2 cytokines 62 inotropic agents 61 intravenous bisphosphonates 61 TMP SMX 61 riociguat 61 analgesic medications 61 fulvestrant 61 paricalcitol 61 interferon alfa 2b 61 verapamil 61 dose proportionality 61 Glucocorticoids 61 griseofulvin 61 gemifloxacin 61 analgesic effects 61 linear pharmacokinetics 61 concomitant medications 61 thienopyridines 61 hepatotoxic 61 GnRH agonists 61 antiepileptics 61 INVEGA ™ 61 nelfinavir 61 interferon ribavirin 61 statins fibrates 61 β blockers 61 lipid lowering therapy 61 fibrinolytic 61 BYSTOLIC 61 sulphonylureas 61 antiarrhythmic 61 immunosuppressive therapies 61 potassium sparing diuretics 61 plasma lipid 61 NMDA antagonist 61 acid suppressing 61 cardiovascular calcification 61 direct thrombin inhibitors 61 LATUDA 61 hematological parameters 61 inhibit platelet function 61 chemopreventive agents 61 tiotropium bromide 61 leukotriene receptor antagonists 61 antitumor effects 60 tricyclic antidepressant 60 NUCYNTA ™ 60 renal toxicity 60 NIASPAN 60 antiangiogenic 60 Tasigna prolongs 60 phenytoin 60 p# activation 60 beta agonists 60 intensive statin therapy 60 pharmacological approaches 60 dihydroergotamine 60 Dasatinib 60 Corticosteroids 60 VAPRISOL 60 ddI 60 coxibs 60 weekly subcutaneous injections 60 adrenal suppression 60 Topiramate 60 factor TNF 60 androgen suppression 60 Avandia Actos 60 antihypertensive therapy 60 inhaled bronchodilators 60 K ras mutations 60 immunomodulatory effects 60 mycophenolate mofetil 60 antiandrogen 60 anti androgen 60 antidiabetic 60 DMARDS 60 tamoxifen Nolvadex ® 60 bronchodilators 60 ACEIs 60 ZOLINZA 60 ABCB1 60 somatostatin analogs 60 Coumadin warfarin 60 heparins 60 CYP#A# inhibitor 60 NATRECOR ® 60 antiandrogens 60 ACE Inhibitors 60 nucleoside analogues 60 zolmitriptan 60 Diovan HCT 60 INVEGA ® 60 ACTOplus met XR 60 angiotensin converting enzyme inhibitors 60 N acetylcysteine 60 statin medications 60 itraconazole 60 hypotensive 60 inhaled bronchodilator 60 nicardipine 60 Anthracycline 60 Triptan 60 antiemetics 60 efalizumab 60 Tylenol acetaminophen 60 Carvedilol 60 therapeutic regimens 60 imatinib resistance 60 coadministration 60 immunological responses 60 inhaled glucocorticoids 60 glitazones 60 abacavir lamivudine 60 antiplatelet therapies 60 topical corticosteroids 59 extrapyramidal symptoms 59 Muscle relaxants 59 venlafaxine Effexor 59 RAS blockers 59 nonnucleoside reverse transcriptase inhibitors 59 Th1 type 59 Anticholinergic 59 vasomotor symptoms 59 antidepressive 59 erythropoietic 59 sotalol 59 motesanib 59 CNS depressant 59 venlafaxine 59 Known hypersensitivity 59 tranylcypromine 59 NUCYNTA TM 59 EXJADE 59 empiric therapy 59 Pioglitazone 59 AVANDIA 59 QTc prolongation 59 acamprosate 59 glucose lowering 59 interferon IFN 59 L dopa 59 Interferon alpha 59 tiagabine 59 H2 receptor antagonists 59 anticancer activity 59 fibrate drugs 59 Fluticasone 59 KETEK 59 nicotinic acid 59 Prilosec omeprazole 59 ramelteon 59 oral antidiabetes drugs 59 nonpharmacologic 59 maximally tolerated dose 59 ATACAND 59 #mg dose [001] 59 citalopram Celexa 59 AGILECT R 59 thiazide diuretics 59 Teriflunomide 59 metastatic neuroendocrine tumors 59 tricyclic antidepressants 59 benazepril 59 desmopressin 59 CIMZIA ™ 59 tricyclics 59 paroxetine Paxil 59 esomeprazole Nexium 59 thromboembolic disease 59 hepatotoxicity 59 Symadex 59 antitumor effect 59 non selective NSAIDs 59 RISPERDAL ® 59 platelet inhibitor 59 pleiotropic effects 59 aminotransferases 59 flutamide 59 muscarinic 59 fluvastatin 59 antihypertensive agents 59 neuropsychiatric symptoms 59 FUSILEV enhances 59 beta lactam antibiotic 59 EEG abnormalities 59 danazol 59 cardio protective 59 sulfasalazine 59 dosage regimens 59 paroxetine sertraline 59 cardiotoxic 59 canakinumab 59 opiods 59 PREZISTA r 59 oxcarbazepine 59 overlapping toxicities 59 tegaserod 59 isoproterenol 59 immune modulating 59 sertraline Zoloft 59 Danazol 59 Lopid 59 poststroke depression 59 PRECAUTIONS Drug Interactions 59 nonsteroidal 59 COX inhibitors 59 nevirapine Viramune 59 Antihistamines 59 BANZEL 59 antiplatelet agent 59 HAART regimens 59 neuroleptic 59 colesevelam 59 immune suppressing 59 guanfacine 59 Paliperidone 59 antianginal 59 EGFR inhibitors 59 serotonin reuptake inhibitors 59 dopamine antagonists 59 hydralazine 58 neutropenic patients 58 DFMO 58 anxiolytic 58 statin simvastatin 58 coinfected patients 58 plasminogen activators 58 Combination therapy 58 leukotriene receptor antagonist 58 ropinirole 58 immunomodulation 58 PKC inhibitors 58 torsade de pointes 58 Starlix 58 mu opioid agonists 58 LDL lowering 58 NUCYNTA ® 58 antiarrhythmic drugs 58 neuroleptics 58 teriparatide 58 clinically meaningful differences 58 trastuzumab Herceptin ® 58 atazanavir 58 Bisphosphonate 58 prednisone prednisolone 58 hemorrhagic complications 58 EGFRIs 58 statins cholesterol lowering 58 oral prodrug 58 Abatacept 58 TDF FTC 58 KAPIDEX 58 cardioprotection 58 protease inhibitor PI 58 Vildagliptin 58 tolerability profiles 58 Paxil paroxetine 58 virologic responses 58 cytoprotective 58 anticonvulsant medications 58 angiotensin II receptor blockers 58 leflunomide 58 Subgroup analyzes 58 pharmacologic approaches 58 mixed hyperlipidemia 58 rosuvastatin #mg 58 TNF alpha inhibitor 58 zoledronate 58 perioperatively 58 Fingolimod 58 loop diuretics 58 antibiotic prophylaxis 58 monoamine oxidase inhibitors MAOIs 58 haloperidol Haldol 58 macrolide antibiotic 58 chemopreventive agent 58 insulin detemir 58 extrapyramidal symptoms EPS 58 sorafenib tablets 58 β blocker 58 reflux symptoms 58 anakinra 58 subcutaneous insulin 58 rituximab Rituxan 58 COREG 58 Gefitinib 58 pharmacological interventions 58 mecamylamine 58 Zileuton 58 innate immune responses 58 pathophysiological effects 58 anti androgens 58 Tolvaptan 58 MAOIs 58 Spironolactone 58 hyperalgesia 58 Sitagliptin 58 Platinol ® cisplatin 58 quinolone antibiotics 58 INVEGA ® SUSTENNA ® 58 buspirone 58 Hypocalcemia 58 EFFEXOR XR 58 zafirlukast 58 Acetaminophen Tylenol 58 antihypertensive drugs 58 gastrointestinal absorption 58 selenium supplementation 58 TRAIL induced apoptosis 58 pharmacokinetic parameters 58 systemic corticosteroid 58 proliferative diabetic retinopathy 58 reuptake inhibitor 58 QT prolongation 58 SUSTENNA TM 58 poor metabolizers 58 ULTRAM ER 58 receptor inhibitor 58 Mg Uk 58 transaminase elevations 58 ovarian hormones 58 cardioprotective effects 58 impair fertility 58 antidepressant efficacy 58 MULTAQ 58 Antacids 58 metformin sulfonylurea 58 EGFR tyrosine kinase inhibitors 58 hawthorn extract 58 laropiprant 58 pharmacologic treatments 58 dosing frequency 58 alkylating agent 58 infliximab Remicade 58 mTOR inhibitors 58 acarbose 58 molecular weight heparins 58 enzyme inhibitor 58 desvenlafaxine succinate 58 remifentanil 58 ACTEMRA TM 58 antithrombotics 58 salicylates 58 diclofenac Voltaren 58 VEGF inhibitors 58 eszopiclone 58 comorbid depression 58 platelet inhibition 58 flavopiridol 58 teriflunomide 58 anti leukemic 58 long acting bronchodilator 58 B7 H3 58 Vaprisol 58 aldosterone antagonist 58 agonist antagonist 58 statin cholesterol lowering 58 Homeopathic medicines 58 alteplase 57 administered subcutaneously 57 anxiolytics 57 Aptivus ® 57 primary aldosteronism 57 colorectal liver metastases 57 oral rivaroxaban 57 NATRECOR R 57 folinic acid 57 oral corticosteroid 57 adriamycin 57 act synergistically 57 endothelin receptor antagonists 57 oral NSAIDs 57 immune modulatory 57 nausea vomiting constipation 57 H. pylori eradication 57 RLAI 57 factor Xa 57 tibolone 57 abciximab 57 glycoprotein IIb IIIa inhibitors 57 mg Pycnogenol 57 adrenocorticotropic hormone 57 Mitomycin C 57 severe hypersensitivity reactions 57 dopamine receptor agonist 57 COX 2s 57 anticholinergic 57 warfarin Coumadin 57 IgE mediated 57 cortical excitability 57 insulin sensitizing 57 erlotinib Tarceva 57 N acetyl cysteine 57 newer atypical antipsychotics 57 KRAS status 57 antihypertensive medications 57 ibandronate 57 macrovascular disease 57 oral antidiabetic medication 57 inhibitory neurotransmitters 57 Exacerbations 57 H2 blockers 57 Hydroxyurea 57 immunosuppressive regimen 57 glatiramer 57 proinflammatory cytokine 57 dextromethorphan DM 57 AChE inhibitors 57 rhTSH 57 anticoagulant medications 57 SSRI antidepressant 57 corticosteroids 57 antiresorptive 57 lamotrigine 57 Itraconazole 57 imipramine 57 lipid lowering agents 57 posaconazole 57 induce orthostatic hypotension 57 lipid lowering drugs 57 pegylated interferons 57 glucocorticoids 57 QT interval prolongation 57 pramlintide metreleptin combination 57 mu opioid 57 hydroxychloroquine 57 meropenem 57 moderate renal impairment 57 adiponectin levels 57 FGFs 57 electro acupuncture 57 standard chemotherapy regimens 57 acetaminophen paracetamol 57 Telmisartan 57 lipid lowering medications 57 azelaic acid 57 medroxyprogesterone 57 CYT# potent vascular disrupting 57 elevated serum creatinine 57 nifedipine 57 NPH insulin 57 thromboembolic events 57 hyperkalemia 57 endocannabinoid signaling 57 antiplatelet therapy 57 visilizumab 57 quinidine 57 opioid antagonist 57 saline placebo 57 nonpharmacological 57 CYP#C# [001] 57 ibuprofen aspirin 57 Dyspepsia Tachycardia Myalgia etc. 57 antiangiogenic therapy 57 atypical neuroleptics 57 systemic immunosuppressive 57 opioid naive 57 nephrotoxic 57 alpha 2A 57 opiod 57 rifamycins 57 hepatic function 57 bromocriptine 57 TNF blocker therapy 57 synthetic progestin 57 Aggrastat ® tirofiban hydrochloride 57 calcitriol 57 hematopoietic cancers 57 BEXXAR Therapeutic Regimen 57 endometrial hyperplasia 57 myoclonus 57 prophylactic anticoagulation 57 hypercholesterolaemia 57 tDCS 57 FASLODEX 57 Demonstrated Significant 57 nephrotoxicity 57 anticancer treatments 57 CYP #D# 57 anticonvulsant medication 57 Triptans 57 androgen deprivation 57 vasoconstrictor 57 tumor histology 57 preoperative chemotherapy 57 VDAs 57 lorazepam Ativan 57 dermatologic reactions 57 HPA axis suppression 57 endogenous hormones 57 alefacept 57 ZOMETA 57 anticholinergic drugs 57 tirofiban 57 Selective Serotonin Reuptake Inhibitor 57 NMDA antagonists 57 Vimpat R 57 relapsed MM 57 Valproate 57 phenelzine 57 immunosuppressives 57 anticonvulsant drugs 57 thiazides 57 #mg/day [002] 57 alfa 2a 57 synovial fibroblasts 57 plasma pharmacokinetics 57 Atypical antipsychotics 57 CYP#D# genotype 57 receptor subtypes 57 dexmedetomidine 57 conventional DMARDs 57 allopregnanolone 57 solifenacin 57 clopidogrel Plavix 57 hematologic toxicity 57 MMP inhibitors 57 non selective NMDA 57 rabeprazole 57 tolvaptan 57 Gonadotropin 57 selective inhibition 57 cholinesterase inhibitors 57 receiving XGEVA 57 EBV infection 57 MAXALT 57 recurrent glioblastoma multiforme 57 gabapentin Neurontin 57 ß blockers 57 serotonin norepinephrine reuptake inhibitors 57 rosuvastatin Crestor 57 bronchodilation 57 Victoza R 57 acid secretion 57 pegylated liposomal doxorubicin 57 fibrinolysis 57 potentiation 57 Prostacyclin 57 CANCIDAS 57 Crestor rosuvastatin 57 idarubicin 56 TriRima 56 alfuzosin 56 angiotensin converting enzyme inhibitor 56 Thiovir 56 Bosentan 56 lipid parameters 56 TNF antagonist 56 warfarin erythromycin 56 QTc intervals 56 lowering blood glucose 56 NR2B selective 56 androgen ablation 56 triiodothyronine 56 salicylate 56 5 HT2A receptor 56 TNF alpha antagonist 56 serum phosphorous 56 nasopharyngitis headache 56 bicalutamide 56 montelukast 56 IL 1ß 56 mg ritonavir 56 Nonsteroidal anti inflammatory 56 aminophylline 56 tolterodine ER 56 potentially hepatotoxic 56 antithrombotic 56 moderate hepatic impairment 56 hyperprolactinemia 56 oral anticoagulation 56 LY# [003] 56 paliperidone 56 ketoconazole 56 immune suppressants 56 INVEGA R 56 GnRH agonist 56 Ropinirole 56 nonsteroidal antiinflammatory drugs 56 Lipitor #mg 56 NRTIs 56 serotonergic agents 56 rufinamide 56 pyrimethamine 56 Pemetrexed 56 CIMZIA R 56 strong CYP#A# inducers 56 aromatase inhibitor therapy 56 DACH platinum 56 Phe restricted diet 56 acute porphyria 56 DMARDs 56 CIMZIA TM 56 triglyceride lowering 56 platelet activation 56 biologic pathways 56 TNF inhibitor 56 prazosin 56 dopamine agonists 56 BENICAR HCT 56 FOLPI 56 TELINTRA 56 lipid lowering medication 56 nausea constipation 56 FRAGMIN R 56 FOSRENOL ® 56 systemic hypotension 56 Adalimumab 56 Anticonvulsants 56 cilostazol 56 thyroxine 56 nadolol 56 prostacyclins 56 atorvastatin Lipitor 56 antiplatelet 56 TMC# r 56 pioglitazone HCl 56 aplindore 56 antidiabetic medications 56 PR interval prolongation 56 immunomodulatory therapy 56 chlorthalidone 56 Patients Receiving 56 contra indications 56 pharmacologically 56 anthracycline chemotherapy 56 Lubiprostone 56 pharmacotherapies 56 ribavirin USP 56 interferon therapy 56 tocilizumab 56 DAPT 56 IGFBP 3 56 LT NS# 56 antirheumatic 56 sedating antihistamine 56 LEXIVA 56 sedating medications 56 Aliskiren 56 Venlafaxine 56 steroid inhalers 56 hydrolyzed formula 56 risedronate Actonel 56 rFVIIa 56 Tranexamic acid 56 psychostimulants 56 miconazole 56 urate lowering 56 raloxifene Evista 56 immunosuppressant drug 56 HuR 56 NSAIDs 56 testosterone supplementation 56 caspofungin 56 intravenous cyclophosphamide 56 d4T 56 low dose ritonavir 56 Valproic acid 56 inhaled anesthetics 56 anticlotting 56 ergot derivatives 56 conventional antipsychotics 56 pleiotropic 56 glomerular filtration 56 nonhematologic adverse reactions 56 oral anticoagulant therapy 56 beta adrenergic receptors 56 mutated KRAS gene 56 fibrinolytic therapy 56 NMDA receptor antagonists 56 gemcitabine Gemzar 56 gp# vaccine 56 esomeprazole 56 antiepileptic drugs AEDs 56 LYSTEDA 56 Hepatotoxicity 56 aripiprazole Abilify 56 salmeterol fluticasone 56 EMSAM 56 severe hepatic insufficiency 56 trimethoprim sulfamethoxazole 56 CETP inhibition 56 vasodilator 56 BoNTA 56 rHuEPO 56 irbesartan 56 cediranib 56 conjugated estrogen 56 Infliximab 56 remyelination 56 Helicobacter pylori eradication 56 opioid naïve 56 tardive dyskinesia TD 56 HPA axis 56 constipation nausea 56 SERMs 56 dopaminergic therapy 56 noscapine 56 lanreotide 56 alpha blocker 56 breast cancer subtypes 56 guanfacine extended release 56 intracranial hemorrhage ICH 56 PDE4 inhibitors 56 thrombotic complications 56 IV bisphosphonates 56 Ambrisentan 56 dose statin therapy 56 IFN γ 56 SUSTIVA 56 norethindrone acetate 56 sedating antihistamines 56 Focalin XR 56 prolonged QT interval 56 MEVACOR 56 pharmacologic 56 acitretin 56 short acting bronchodilator 56 inhibits platelet aggregation 56 intranasally administered 56 colorectal carcinogenesis 56 ovarian carcinoma 56 thrombotic events 56 antithrombotic agent 56 hypercalcemia 56 efavirenz Sustiva 56 somatostatin analogues 56 fibrates 56 thioridazine 56 acid reducers 56 CNS depressants 56 abrupt discontinuation 56 Thal Dex 56 peginterferon 56 serum BDNF 56 Erlotinib 56 Guaifenesin 56 antiviral efficacy 56 bevacizumab Avastin Genentech 56 piroxicam 56 antiapoptotic 56 tenofovir Viread 56 AZILECT R 56 pregabalin 56 headache dizziness fatigue 56 nonstimulant 56 serum leptin 56 hour bronchodilation 56 didanosine associated 56 HIV HCV coinfected 56 Ivabradine 56 Clinical Relevance 56 cortisone creams 56 Zyban bupropion 56 IgG4 56 proton pump inhibitor 56 buprenorphine naloxone 56 carbidopa 56 pharmacokinetic PK profile 56 haematologic 56 inhaled iloprost 55 lansoprazole Prevacid 55 ovarian suppression 55 sulphonylurea 55 ximelagatran 55 HER2 overexpression 55 HIV protease inhibitors 55 surgical debulking 55 Kaplan Meier curve 55 indomethacin 55 ACE inhibitor lisinopril 55 Ramipril 55 CONCERTA 55 fatal anaphylactic 55 tolterodine 55 risperidone Risperdal 55 glatiramer acetate 55 Ischemic 55 budesonide pMDI 55 Hypersensitivity reactions 55 apremilast 55 cabergoline 55 idraparinux 55 inotropes 55 oral antihistamines 55 refractory gout 55 #mg/day [001] 55 icatibant 55 pharmacologically active isomer 55 partial agonist 55 biologic plausibility 55 inhaled budesonide 55 levosimendan 55 anticonvulsants 55 narcotic analgesics 55 Treg cell 55 fumagillin nanoparticles 55 anti emetics 55 hypomagnesemia 55 lipid abnormalities 55 quetiapine Seroquel 55 hormone therapy estrogen 55 SAMe 55 Abrupt discontinuation 55 hypocalcaemia 55 receptor blocker 55 doxorubicin cyclophosphamide 55 opioid medications 55 SSRI SNRI 55 containing abacavir 55 anti convulsants 55 Salmeterol 55 immunosuppressive regimens 55 Beta agonists 55 dyslipidemic 55 serum antibodies 55 opiate analgesics 55 Nonspecific 55 Pramipexole 55 iloprost 55 pulmonary exacerbations 55 prochlorperazine 55 ZD# [001] 55 olmesartan 55 cefuroxime 55 monoamine oxidase inhibitor 55 ULORIC 55 EXALGO 55 telcagepant 55 Antidepressant medications 55 Coadministration 55 KRAS mutation 55 monoclonal antibody Rituxan 55 valproic acid 55 cholinesterase inhibitor 55 selegiline 55 droperidol 55 TEAEs 55 tapentadol IR 55 divalproex sodium 55 postmenopausal hormone therapy 55 postoperative AF 55 vasoactive 55 apneic episodes 55 calcium antagonist 55 ergotamine 55 glulisine 55 immunomodulatory 55 antiseizure drug 55 H2 blocker 55 diabetic gastroparesis 55 neurotransmitter GABA 55 antidiabetic drugs 55 anti angiogenic agents 55 dose ritonavir 55 insulin secretagogue 55 parkinsonian symptoms 55 anti angiogenic drugs 55 Rofecoxib 55 Hematologic toxicity 55 proteasome inhibitors 55 pressor response 55 Yohimbine 55 Juvenile Idiopathic Arthritis 55 tricyclic 55 dexrazoxane 55 estrogen progesterone 55 antiinflammatory drugs 55 dyslipidemias 55 ApoA1 55 epoetin beta 55 ganaxolone 55 neuraminidase inhibitors 55 seminomas 55 orthostatic hypotension 55 Unstable angina 55 TLR9 mediated immune 55 dose titration 55 lispro 55 hormone deprivation 55 Clot busting 55 Methylnaltrexone 55 include ketoconazole acetaminophen 55 insulin sensitization 55 pramipexole 55 chronic lyme 55 pravastatin Pravachol 55 Drospirenone 55 included exfoliative dermatitis 55 inhibitory effects 55 thienopyridine 55 GI bleeds 55 relapsed ovarian cancer 55 Risperidone 55 strong CYP#A# inhibitors 55 Nifedipine 55 Dapagliflozin 55 Nasal polyps 55 COPD exacerbations 55 potassium supplements 55 inhaled corticosteroids ICS 55 HER2 expression 55 Tolerability 55 EDARBI 55 glucose abnormalities 55 proton pump inhibitors PPIs 55 oral antidiabetes 55 Parnate 55 d4T stavudine Zerit 55 glucocorticoid 55 Etanercept 55 antitumour 55 severe renal impairment 55 anticholinergic agents 55 pharmacokinetic characteristics 55 Carbamazepine 55 venlafaxine ER 55 endocrine therapies 55 gastric irritation 55 symptomatic hyponatremia 55 genital tract infections 55 Opioids 55 myelosuppression 55 valproate 55 nitrotyrosine 55 amifostine 55 Hedgehog inhibitor 55 esophagogastric 55 renal insufficiency 55 betamethasone dipropionate 55 renoprotective 55 antiplatelet medication 55 gadobutrol 55 hematological toxicity 55 paracetamol acetaminophen 55 cAMP signaling 55 systemic corticosteroids 55 NSAID associated 55 cis retinoic acid 55 endotoxemia 55 Oral Fingolimod 55 vandetanib 55 etiologic